FDA Drug recall D-0641-2022
All Over-The-Counter (OTC) drug products sold by Family Dollar retail stores located in Alabama, Arkansas, Louisiana, Mississippi, Missouri…
- FDA Drug
- Class II
- ongoing
- Published 2022-03-09
On 2022-03-09 the FDA classified a Class II recall of All Over-The-Counter (OTC) drug products sold by Family Dollar retail stores located in Alabama, Arkansas, Louisiana, Mississippi, Missouri… by Dollar Tree Distribution, citing CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0641-2022 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2022-02-18 |
| Published | 2022-03-09 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dollar Tree Distribution |
| Distribution | AL, AR, LA, MO, MS, TN |
Product
All Over-The-Counter (OTC) drug products sold by Family Dollar retail stores located in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee.
Reason
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.
Identifiers
| code_info | All drug products sold by Family Dollar retail stores located in AL, AR, LA, MS, MO, and TN from January 1, 2021 to present. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0641-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.